BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 11303132)

  • 1. Denervated stomach as an esophageal substitute recovers intraluminal acidity with time.
    Gutschow C; Collard JM; Romagnoli R; Salizzoni M; Hölscher A
    Ann Surg; 2001 Apr; 233(4):509-14. PubMed ID: 11303132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined 24-hour intraluminal pH and bile monitoring of the denervated whole stomach as an esophageal substitute.
    Romagnoli R; Bechi P; Salizzoni M; Collard JM
    Hepatogastroenterology; 1999; 46(25):86-91. PubMed ID: 10228769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile exposure of the denervated stomach as an esophageal substitute.
    Gutschow CA; Collard JM; Romagnoli R; Michel JM; Salizzoni M; Hölscher AH
    Ann Thorac Surg; 2001 Jun; 71(6):1786-91. PubMed ID: 11426748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What influences the acidity in the gastric conduit in patients who underwent cervical esophagogastrostomy for cancer?
    Tsubuku T; Fujita H; Tanaka T; Matono S; Nishimura K; Murata K; Sueyoshi S; Shirouzu K; Aoyama Y; Yanagawa T
    Dis Esophagus; 2011 Nov; 24(8):575-82. PubMed ID: 21489042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy.
    Menges M; Müller M; Zeitz M
    Am J Gastroenterol; 2001 Feb; 96(2):331-7. PubMed ID: 11232672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional foregut abnormalities in Barrett's esophagus.
    Stein HJ; Hoeft S; DeMeester TR
    J Thorac Cardiovasc Surg; 1993 Jan; 105(1):107-11. PubMed ID: 8419690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-four hour monitoring of pH in the gastric tube replacing the resected esophagus.
    Hashimoto M; Imamura M; Shimada Y; Shirakata Y; Takeuchi K
    J Am Coll Surg; 1995 Jun; 180(6):666-72. PubMed ID: 7773479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized.
    Kauer WK; Peters JH; DeMeester TR; Ireland AP; Bremner CG; Hagen JA
    Ann Surg; 1995 Oct; 222(4):525-31; discussion 531-3. PubMed ID: 7574932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors relieve and prevent symptoms related to gastric acidity after esophagectomy.
    Okuyama M; Motoyama S; Maruyama K; Sasaki K; Sato Y; Ogawa J
    World J Surg; 2008 Feb; 32(2):246-54. PubMed ID: 18064513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric acid hypersecretion in refractory gastroesophageal reflux disease.
    Collen MJ; Lewis JH; Benjamin SB
    Gastroenterology; 1990 Mar; 98(3):654-61. PubMed ID: 2298369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of acid and alkaline reflux in patients with Barrett's esophagus. G.O.S.P.E. Operative Group for the study of Esophageal Precancer.
    D'Onofrio V; Bovero E; Iaquinto G
    Dis Esophagus; 1997 Jan; 10(1):16-22; discussion 22-3. PubMed ID: 9079268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new physiologic approach for the surgical treatment of patients with Barrett's esophagus: technical considerations and results in 65 patients.
    Csendes A; Braghetto I; Burdiles P; Díaz JC; Maluenda F; Korn O
    Ann Surg; 1997 Aug; 226(2):123-33. PubMed ID: 9296504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed esophageal function and morphological analysis shows high prevalence of gastroesophageal reflux disease and Barrett's esophagus in patients with cervical inlet patch.
    Rosztóczy A; Izbéki F; Németh IB; Dulic S; Vadászi K; Róka R; Gecse K; Gyökeres T; Lázár G; Tiszlavicz L; Wittmann T
    Dis Esophagus; 2012 Aug; 25(6):498-504. PubMed ID: 22107367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus.
    Csendes A; Smok G; Cerda G; Burdiles P; Mazza D; Csendes P
    Dis Esophagus; 1997 Jan; 10(1):38-42. PubMed ID: 9079272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac mucosa in the remnant esophagus after esophagectomy is an acquired epithelium with Barrett's-like features.
    Lord RV; Wickramasinghe K; Johansson JJ; Demeester SR; Brabender J; Demeester TR
    Surgery; 2004 Sep; 136(3):633-40. PubMed ID: 15349112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The denervated stomach as an esophageal substitute is a contractile organ.
    Collard JM; Romagnoli R; Otte JB; Kestens PJ
    Ann Surg; 1998 Jan; 227(1):33-9. PubMed ID: 9445107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The place of gastro-jejuno-duodenal interposition following limited esophageal resection.
    Altorjay A; Kiss J; Paál B; Tihanyi Z; Luka F; Farsang Z; Asztalos I; Altorjay I
    Eur J Cardiothorac Surg; 2005 Aug; 28(2):296-300. PubMed ID: 15963730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric and esophageal pH in patients with Barrett's esophagus treated with three esomeprazole dosages: a randomized, double-blind, crossover trial.
    Spechler SJ; Sharma P; Traxler B; Levine D; Falk GW
    Am J Gastroenterol; 2006 Sep; 101(9):1964-71. PubMed ID: 16848802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.